BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7583019)

  • 21. Inhibition of heat shock transcription factor by GR.
    Wadekar SA; Li D; Periyasamy S; Sánchez ER
    Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.
    Whitacre DC; Karnas KJ; Miesfeld RL
    Endocrine; 2001 Jun; 15(1):111-8. PubMed ID: 11572317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members.
    Ma S; Rao L; Freedberg IM; Blumenberg M
    Gene Expr; 1997; 6(6):361-70. PubMed ID: 9495317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
    Uht RM; Anderson CM; Webb P; Kushner PJ
    Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
    Adcock IM; Lane SJ; Brown CR; Lee TH; Barnes PJ
    J Exp Med; 1995 Dec; 182(6):1951-8. PubMed ID: 7500041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin.
    Tuckermann JP; Reichardt HM; Arribas R; Richter KH; Schütz G; Angel P
    J Cell Biol; 1999 Dec; 147(7):1365-70. PubMed ID: 10613894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-jun N-terminal kinase in systemic lupus erythematosus patients.
    Oikonomidou O; Vlachoyiannopoulos PG; Kominakis A; Kalofoutis A; Moutsopoulos HM; Moutsatsou P
    Neuroimmunomodulation; 2006; 13(4):194-204. PubMed ID: 17347585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of NF-kappaB and AP-1 activation in icariin promoted cardiac differentiation of mouse embryonic stem cells.
    Wo Y; Zhu D; Yu Y; Lou Y
    Eur J Pharmacol; 2008 May; 586(1-3):59-66. PubMed ID: 18423597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A thyroid hormone receptor-dependent glucocorticoid induction.
    Leers J; Steiner C; Renkawitz R; Muller M
    Mol Endocrinol; 1994 Apr; 8(4):440-7. PubMed ID: 8052265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of cellular transformation by glucocorticoid receptor mutants.
    Kameda T; Iba H
    Cancer Res; 1998 Mar; 58(5):867-70. PubMed ID: 9500440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
    Manna PR; Eubank DW; Stocco DM
    Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element.
    Flick MB; Sapi E; Kacinski BM
    J Cell Biochem; 2002; 85(1):10-23. PubMed ID: 11891846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun.
    Touray M; Ryan F; Jaggi R; Martin F
    Oncogene; 1991 Jul; 6(7):1227-34. PubMed ID: 1650443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk of CREB and Fos/Jun on a single cis-element: transcriptional repression of the steroidogenic acute regulatory protein gene.
    Manna PR; Stocco DM
    J Mol Endocrinol; 2007 Oct; 39(4):261-77. PubMed ID: 17909266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
    Kilbey A; Black EJ; Unlu M; Gillespie DA
    Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters.
    Rutberg SE; Saez E; Lo S; Jang SI; Markova N; Spiegelman BM; Yuspa SH
    Oncogene; 1997 Sep; 15(11):1337-46. PubMed ID: 9315102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coordinate regulation of glucocorticoid receptor and c-jun mRNA levels: evidence for cross-talk between two signaling pathways' at the transcriptional level.
    Vig E; Barrett TJ; Vedeckis WV
    Mol Endocrinol; 1994 Oct; 8(10):1336-46. PubMed ID: 7854351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.